Ligand validation:4CJB

A2G: 2-acetamido-2-deoxy-alpha-D-galactopyranose

A2G is a Ligand Of Interest in 4CJB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CJB_A2G_B_1237	6%	47%	0.333	0.756	0.53	1.53	-	3	0	0	100%	0.7
4CJB_A2G_A_1237	4%	42%	0.369	0.748	0.56	1.74	-	4	5	0	100%	0.65
4CJB_A2G_D_1236	4%	70%	0.328	0.705	0.41	0.71	-	-	2	0	100%	0.81
4CJB_A2G_C_1238	2%	41%	0.39	0.697	0.45	1.86	-	3	1	0	100%	0.77
4CJ8_A2G_D_1238	38%	78%	0.2	0.905	0.41	0.47	-	-	0	0	100%	1
2A2D_A2G_A_459	99%	14%	0.053	0.991	1.08	2.92	1	6	0	0	100%	1
5T5P_A2G_b_201	99%	29%	0.046	0.982	1.11	1.86	2	3	0	0	100%	0.9333
5T5J_A2G_a_201	99%	43%	0.049	0.983	0.94	1.31	-	2	0	0	100%	0.9333
8PN5_A2G_I_101	99%	31%	0.049	0.98	1.82	1.08	3	1	0	0	100%	0.9333
5XG5_A2G_A_201	98%	41%	0.053	0.977	1.35	1.01	3	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.